Advanced in Obesity in Children

Dr. Ashley Shoemaker

Pediatric Endocrinology
Vanderbilt University
2200 Childrens Way, 
Nashville, TN 
Offers Telehealth
Advanced in Obesity in Children
Vanderbilt University
2200 Childrens Way, 
Nashville, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ashley Shoemaker is a Pediatric Endocrinologist in Nashville, Tennessee. Dr. Shoemaker is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. Her top areas of expertise are Albright's Hereditary Osteodystrophy, Pseudohypoparathyroidism, Prader-Willi Syndrome, and Obesity.

Her clinical research consists of co-authoring 50 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles and participated in 2 clinical trials in the study of Obesity in Children.

Specialties
Pediatric Endocrinology
Licenses
Pediatric Endocrinology in TN
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
View 9 Less Insurance Carriers -

Locations

Vanderbilt University
2200 Childrens Way, Nashville, TN 37232
Other Locations
Office
1215 21st Ave S, Nashville, TN 37232

Additional Areas of Focus

Dr. Shoemaker has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism
Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2025
Intervention Type: Drug
Study Drug: Theophylline
Study Phase: Phase 2
Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism
Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2025
Intervention Type: Drug
Study Drug: Theophylline
Study Phase: Phase 2
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2/Phase 3
Vanderbilt Childhood Obesity Registry
Vanderbilt Childhood Obesity Registry
Enrollment Status: Active_not_recruiting
Publish Date: March 12, 2025
A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
Enrollment Status: Completed
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Enrollment Status: Completed
Publish Date: April 19, 2024
Intervention Type: Drug
Study Drug: DCCR (diazoxide choline controlled release tablets)
Study Phase: Phase 3
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome
Enrollment Status: Terminated
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drug: RAD011
Study Phase: Phase 2/Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Enrollment Status: Completed
Publish Date: November 15, 2022
Glucagon-Like Peptide-1 Agonist Effects on Energy Balance in Hypothalamic Obesity
Glucagon-Like Peptide-1 Agonist Effects on Energy Balance in Hypothalamic Obesity
Enrollment Status: Completed
Publish Date: May 05, 2022
Intervention Type: Drug
Study Phase: Phase 3
Glucose Homeostasis and Beta Cell Function in Pseudohypoparathyroidism
Glucose Homeostasis and Beta Cell Function in Pseudohypoparathyroidism
Enrollment Status: Terminated
Publish Date: May 27, 2021
A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: March 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
Enrollment Status: Completed
Publish Date: November 13, 2019
View 13 Less Clinical Trials
Similar Doctors
Experienced in Obesity in Children
Dr. Jaclyn Tamaroff
Pediatric Endocrinology
Experienced in Obesity in Children
Dr. Jaclyn Tamaroff
Pediatric Endocrinology

Vanderbilt University

3601 21st Ave S, 
Nashville, TN 
 (0.5 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jaclyn Tamaroff is a Pediatric Endocrinologist in Nashville, Tennessee. Dr. Tamaroff is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. Her top areas of expertise are Hereditary Ataxia, Brachydactyly, Albright's Hereditary Osteodystrophy, and Pseudohypoparathyroidism.

Experienced in Obesity in Children
Dr. Kristal A. Matlock
Pediatric Endocrinology
Experienced in Obesity in Children
Dr. Kristal A. Matlock
Pediatric Endocrinology

Vanderbilt University Medical Center

1301 Medical Ctr Dr, 
Nashville, TN 
 (0.1 miles away)
615-322-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kristal Matlock is a Pediatric Endocrinologist in Nashville, Tennessee. Dr. Matlock is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. Her top areas of expertise are Neonatal Hypothyroidism, Congenital Hypothyroidism, Type 1 Diabetes (T1D), and Short Stature (Growth Disorders).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shoemaker's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile